The report provides a detailed analysis essential for establishing a Sulfacetamide production plant. It encompasses all critical aspects necessary for Sulfacetamide production, including the cost of Sulfacetamide production, Sulfacetamide plant cost, Sulfacetamide production costs, and the overall Sulfacetamide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Sulfacetamide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Sulfacetamide is a sulfonamide antibiotic that stops bacterial folic acid synthesis via dihydropteroate synthase blockade. It is applied topically in ophthalmic formulations like 10% sodium sulfacetamide drops or ointments for treating bacterial conjunctivitis, keratitis, blepharitis, and trachoma. It provides effective local antimicrobial action with minimal systemic absorption and low resistance potential compared to modern antibiotics. It is available in creams, lotions, washes, or foams (often combined with 5% sulfur for enhanced keratolytic and anti-inflammatory effects). It is used to manage acne vulgaris, rosacea inflammatory lesions, seborrheic dermatitis, and scalp conditions by reducing Propionibacterium acnes colonization, unclogging follicles, and alleviating scaling or pustules.
The market for Sulfacetamide is driven by its growing demand in ophthalmic treatments for bacterial conjunctivitis and dermatological applications. The rising global skin disorder cases affecting large populations, heightened consumer awareness of topical antibiotic benefits, and expanded e-commerce access to formulations fuel its market.
The industrial Sulfacetamide procurement is influenced by its status as a mature generic off-patent drug. The supplier evaluation for GMP certification, Drug Master File compliance, and consistent API quality (CAS 127-56-0) further affects its sourcing. Other factors like cost-effectiveness via bulk negotiations and FTAs, minimizing duties, supply chain reliability amid raw material volatility and geopolitical disruptions, and regulatory demands for bioequivalence and safety testing impact its market dynamics.
Raw Material for Sulfacetamide Production
According to the Sulfacetamide production plant project report, the key raw materials used in the production of Sulfacetamide include 4-Aminobenzenesulfonamide and Acetic Anhydride.
Production Process of Sulfacetamide
The extensive Sulfacetamide production cost report consists of the following major industrial production process:
- From 4-Aminobenzenesulfonamide: The production of Sulfacetamide involves acetylation of sulfanilamide followed by selective hydrolysis of the N4-acetyl group. The process starts by adding 4-aminobenzenesulfonamide acetic anhydride, followed by then refluxing for 2-3 hours. This N1, N4-diacetylsulfanilamide solid is washed with cold water, followed by treatment with a diacetyl derivative with NaOH. The filtrate is acidified and refrigerated for 24 hours to obtain sulfacetamide.
Sulfacetamide has a molecular formula of C8H10N2O3S and a molecular weight of 214.24 g/mol. It appears as a white or yellowish-white crystalline powder or prisms at room temperature. It has a melting point of 182–184 degree Celsius and an acidic, slightly saline taste. It has low water solubility but dissolves readily in mineral acids, alkali hydroxides, carbonates, alcohol, and acetone. It is slightly soluble in ether and very slightly in chloroform. It shows UV maxima around 255–271 nm reflecting its aromatic sulfonamide structure. It has pKa values of 1.8 (amino group) and 5.4 (sulfonamide group), a logP of -0.96, indicating hydrophilic character. It contains two hydrogen bond donors, four acceptors, and a polar surface area of 89.26 Ų that supports its topical and ophthalmic applications.